Phase II/III Study of AZD2816, for the Prevention of COVID-19 in Adults

NCT04973449 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

2843

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
SARS-CoV-2

Interventions

BIOLOGICAL: AZD1222
BIOLOGICAL: AZD2816

Sponsor

AstraZeneca